Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
Condition(s):Relapsed Solid Tumors; Refractory Solid Tumors; Relapsed Leukemia; Refractory LeukemiaLast Updated:January 12, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Relapsed Solid Tumors; Refractory Solid Tumors; Relapsed Leukemia; Refractory LeukemiaLast Updated:January 12, 2024Completed
Condition(s):Hematologic Neoplasms; Multiple Myeloma; Efficacy; SafetyLast Updated:November 29, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:July 13, 2017Unknown status
Condition(s):Advanced/Metastatic Solid Tumors; Relapse/Refractory LymphomaLast Updated:September 22, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:February 11, 2008Completed
Condition(s):Multiple MyelomaLast Updated:June 22, 2010Completed
Condition(s):Multiple Myeloma in Relapse; Multiple Myeloma; Multiple Myeloma, Refractory; Multiple Myeloma With Failed RemissionLast Updated:October 12, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:October 15, 2014Terminated
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Acute Mixed-Phenotype Leukemia; Cancer; Refractory; Progression; Diffuse Large B Cell Lymphoma; Multiple Myeloma; Lymphoma; Lymphoma, Non-Hodgkin; Myeloma, Plasma-Cell; Myelomatosis; Plasma Cell Myeloma; Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:March 5, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:February 1, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.